These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 31399080

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor.
    Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, Aucouturier P, Godin M, Ronco P.
    J Am Soc Nephrol; 2012 Dec; 23(12):1949-54. PubMed ID: 23123401
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The role of complement in membranous nephropathy.
    Ma H, Sandor DG, Beck LH.
    Semin Nephrol; 2013 Nov; 33(6):531-42. PubMed ID: 24161038
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antibodies against M-Type Phospholipase A2 Receptor May Predict Treatment Response and Outcome in Membranous Nephropathy.
    Qu Z, Zhang MF, Cui Z, Wang J, Wang M, Zhang YM, Wang F, Wang X, Meng LQ, Cheng XY, Liu G, Zhao MH.
    Am J Nephrol; 2018 Nov; 48(6):438-446. PubMed ID: 30472708
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Augmented mannose-binding lectin levels in primary membranous nephropathy: A pilot study.
    Pal D, Inamdar N, Kaur P, Singhal M, Lal A, Gorsi U, Nada R, Kohli HS, Kumar V, Ramachandran R.
    Nephrology (Carlton); 2024 Sep; 29(9):617-621. PubMed ID: 38511256
    [Abstract] [Full Text] [Related]

  • 31. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA, Mezzina N, Trezzi B, Ghiggeri GM, Radice A.
    Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.
    Kaga H, Komatsuda A, Yamamoto S, Kikuchi T, Kamata M, Sato A, Odaka M, Yokota SI, Takahashi N, Wakui H.
    Clin Exp Nephrol; 2019 Apr; 23(4):465-473. PubMed ID: 30756249
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H.
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [Abstract] [Full Text] [Related]

  • 40. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S, Kalavrizioti D, Stangou M, Kouri MN, Kalliakmani P, Papasotiriou M, Papachristou E, Goumenos DS, Papagianni A.
    Rom J Intern Med; 2019 Jun 01; 57(2):141-150. PubMed ID: 30864406
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.